cgmp regulations Options
No. 21 CFR 211.113(a) necessitates suitable prepared methods to generally be founded and adopted for the duration of manufacturing to circumvent objectionable microorganisms in drug products not needed to be sterile. Moreover, the second paragraph of USP General Chapter Antimicrobial Effectiveness Tests reads: Antimicrobial preservatives s